Rathbones Group PLC Sells 14,594 Shares of McKesson Corporation $MCK

Rathbones Group PLC lowered its holdings in shares of McKesson Corporation (NYSE:MCK) by 26.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 41,175 shares of the company’s stock after selling 14,594 shares during the quarter. Rathbones Group PLC’s holdings in McKesson were worth $33,775,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. J.W. Cole Advisors Inc. boosted its position in shares of McKesson by 35.3% during the third quarter. J.W. Cole Advisors Inc. now owns 5,089 shares of the company’s stock valued at $3,931,000 after buying an additional 1,329 shares during the period. Cullen Investment Group LTD. boosted its holdings in McKesson by 550.4% during the 4th quarter. Cullen Investment Group LTD. now owns 4,670 shares of the company’s stock valued at $3,811,000 after acquiring an additional 3,952 shares during the period. Private Wealth Partners LLC grew its position in McKesson by 5.6% in the 3rd quarter. Private Wealth Partners LLC now owns 31,841 shares of the company’s stock valued at $24,598,000 after acquiring an additional 1,682 shares during the last quarter. AlphaQuest LLC grew its position in McKesson by 91.2% in the 3rd quarter. AlphaQuest LLC now owns 1,767 shares of the company’s stock valued at $1,365,000 after acquiring an additional 843 shares during the last quarter. Finally, Envestnet Asset Management Inc. increased its stake in McKesson by 12.4% in the third quarter. Envestnet Asset Management Inc. now owns 330,647 shares of the company’s stock worth $255,438,000 after purchasing an additional 36,451 shares during the period. 85.07% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Michele Lau sold 2,725 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the transaction, the executive vice president directly owned 3,247 shares of the company’s stock, valued at approximately $3,214,530. This represents a 45.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The disclosure for this sale is available in the SEC filing. Insiders have sold 3,592 shares of company stock valued at $3,518,555 in the last ninety days. 0.08% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the company. Leerink Partners reiterated an “outperform” rating and set a $1,085.00 target price on shares of McKesson in a research report on Thursday, March 5th. Wall Street Zen raised shares of McKesson from a “hold” rating to a “buy” rating in a research note on Sunday, March 22nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of McKesson in a report on Wednesday, December 10th. Morgan Stanley restated an “overweight” rating and issued a $966.00 target price on shares of McKesson in a research note on Thursday, January 29th. Finally, Evercore reaffirmed an “outperform” rating on shares of McKesson in a research report on Thursday, March 5th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $960.93.

McKesson Price Performance

Shares of MCK stock opened at $885.42 on Monday. The stock’s 50-day moving average is $912.57 and its 200 day moving average is $846.69. McKesson Corporation has a 1-year low of $637.00 and a 1-year high of $999.00. The company has a market cap of $108.45 billion, a P/E ratio of 25.46, a PEG ratio of 1.26 and a beta of 0.42.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. During the same period in the previous year, the company posted $8.03 earnings per share. The firm’s revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, analysts anticipate that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 1st. Investors of record on Monday, March 2nd were given a dividend of $0.82 per share. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio is presently 9.43%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.